Liver preservation below 0 degrees C with UW solution and 2,3-butanediol. 1996

M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
Laboratoire de Recherche Chirurgicale, Faculté de Médecine Cochin-Port Royal, Hôpital Cochin, 27, rue du Faubourg St Jacques, Paris, 75014, France.

Long-term preservation of the liver is needed to transform liver transplantation from an emergency operation to an elective procedure and therefore to improve the results of liver transplantation. We explored the possibility of extending the cold ischemia time of the rat liver by using a preservation temperature below 0 degrees C together with the addition of a cryoprotective agent (2,3-butanediol) at a low concentration in the preservation solution. Rat livers were preserved for 72 h either with UW solution at +4 degrees C (group 1) or with a UW solution, to which 2,3-butanediol at 8% (at +4 degrees C (group 2) or at -4 degrees C (group 3, experimental group)) was added. Following the preservation process, the viability of the livers was assessed using the isolated perfused liver model. Enzymatic release, bile production, and portal venous flow were not significantly different between group 1 and group 3. In the two groups in which preservation included 2,3-butanediol, the enzymatic release was significantly greater when the preservation temperature was +4 degrees C. We conclude that, using this method, preservation of the rat liver below 0 degrees C seems feasible. However, despite its low concentration, some toxicity of 2, 3-butanediol was suspected. This would counterbalance the benefit resulting from the temperature-related decrease of the enzymatic activities involved in cold ischemia damage. The potential advantages of this method need to be confirmed by assessing liver viability using a liver transplantation model.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009926 Organ Preservation The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Organ Preservations,Preservation, Organ,Preservations, Organ
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011887 Raffinose A trisaccharide occurring in Australian manna (from Eucalyptus spp, Myrtaceae) and in cottonseed meal. Gossypose,Melitose,Melitriose
D002072 Butylene Glycols 4-carbon straight chain aliphatic hydrocarbons substituted with two hydroxyl groups. The hydroxyl groups cannot be on the same carbon atom. Butanediols,Dihydroxybutanes,Glycols, Butylene
D003451 Cryoprotective Agents Substances that provide protection against the harmful effects of freezing temperatures. Cryoprotective Agent,Cryoprotective Effect,Cryoprotective Effects,Agent, Cryoprotective,Agents, Cryoprotective,Effect, Cryoprotective,Effects, Cryoprotective
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine

Related Publications

M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
October 1989, Transplantation proceedings,
M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
January 2007, Cryo letters,
M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
February 1989, JAMA,
M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
January 1988, The Journal of heart transplantation,
M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
March 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
January 1984, Zhurnal evoliutsionnoi biokhimii i fiziologii,
M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
April 1990, Transplantation proceedings,
M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
October 1989, Transplantation proceedings,
M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
June 1989, Transplantation,
M Scotte, and P Eschwege, and C Cherruau, and F Fontaliran, and F Moreau, and D Houssin
April 1962, Science (New York, N.Y.),
Copied contents to your clipboard!